Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Finasteride may cause kidney damage.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Dosing time affects finasteride's effectiveness and safety in rats.

Analog 23 is a promising compound for prostate cancer treatment.

Women with alopecia may have a higher chance of getting thyroid cancer.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

The compound was successfully made and shows potential for treating prostate cancer.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Male pattern baldness does not cause an increased risk of prostate cancer.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

CT scans can find serious prostate cancer even when PSA levels are low.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Using finasteride with TIP extends time off period for prostate cancer patients.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.